Manufacturer Intelligence · Based on 21,603 FDA 510(k) records · 72 countries

FDA 510(k) Medical Device Manufacturers - Hong Kong

Hong Kong medical device manufacturers ranked by FDA 510(k) submission volume. This is not a curated directory - rankings reflect real submission activity extracted from FDA accessdata.gov records.

  • Compare manufacturers by FDA 510(k) submission activity
  • Identify clearance rates, active panels and years of FDA activity
  • Filter by country or FDA review panel specialty
10
Manufacturers
Hong Kong
Country

Hong Kong FDA 510(k) Overview

10
Manufacturers
22
Submissions
100%
Clearance rate

Leading Hong Kong FDA 510(k) manufacturers include Bioland Technology, Ltd., Well-Life Healthcare Limited, Belun Technology Company Limited and 7 others.

Hong Kong-based medical device manufacturers have submitted 22 FDA 510(k) notifications since 2020, with a 100% clearance rate across 10 manufacturers. Hong Kong's medtech sector primarily serves as a regional hub for manufacturers targeting both U.S. and Asia-Pacific markets, with activity in diagnostics, monitoring devices and Class II medical equipment.

Active in FDA 510(k) submissions since 2020. Many Hong Kong manufacturers work with FDA regulatory consultants to support U.S. market entry.

FDA 510(k) Hong Kong Manufacturers

1–10 of 10
# Manufacturer Submissions Cleared Active panels Country
1 7 100%
CH CV HO
HK
2 5 100%
GU NE
HK
3 3 100%
AN
HK
4 1 100%
DE
HK
5 1 100%
HO
HK
6 1 100%
SU
HK
7 1 100%
SU
HK
8 1 100%
AN
HK
9 1 100%
CV
HK
10 1 100%
DE
HK

About This FDA 510(k) Manufacturer Database

Data Source and Methodology

Rankings are based on the total number of published FDA 510(k) submissions per manufacturer in the 510k Database dataset, derived from FDA 510(k) public files. This is not a curated or paid listing - manufacturer rankings reflect real regulatory activity.

Used by regulatory affairs teams and medtech consultants to benchmark manufacturer activity, identify predicate device candidates, and analyze competitive positioning across FDA review panels.